Coexpression of CD40 and CD40 ligand in B‐cell lymphoma cells
- 1 October 1998
- journal article
- research article
- Published by Wiley in British Journal of Haematology
- Vol. 103 (1) , 270-275
- https://doi.org/10.1046/j.1365-2141.1998.01031.x
Abstract
The British Journal of Haematology publishes original research papers in clinical, laboratory and experimental haematology. The Journal also features annotations, reviews, short reports, images in haematology and Letters to the Editor.Keywords
This publication has 22 references indexed in Scilit:
- FasGene Mutations in the Canale–Smith Syndrome, an Inherited Lymphoproliferative Disorder Associated with AutoimmunityNew England Journal of Medicine, 1996
- Hierarchical Control of Lymphocyte SurvivalScience, 1996
- Expansion or Elimination of B Cells In Vivo: Dual Roles for CD40- and Fas (CD95)-Ligands Modulated by the B Cell Antigen ReceptorCell, 1996
- CD30 ligand is expressed on resting normal and malignant human B lymphocytesBritish Journal of Haematology, 1996
- Human Native Soluble CD40L Is a Biologically Active Trimer, Processed Inside MicrosomesPublished by Elsevier ,1996
- Fas ligand in human serumNature Medicine, 1996
- The Role of the CD40 Antigen on Malignant B CellsLeukemia & Lymphoma, 1996
- Fas and Fas ligand: lpr and gld mutationsImmunology Today, 1995
- Antibody to the ligand of CD40, gp39, blocks the occurrence of the acute and chronic forms of graft-vs-host disease.Journal of Clinical Investigation, 1994
- Suppression of apoptosis in normal and neoplastic human B lymphocytes by CD40 ligand is independent of Bcl‐2 inductionEuropean Journal of Immunology, 1993